Miguel Trevino
Internal Medicine · Clearwater, FLNPI 1760411029
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $14,191 of the $23,604 with a category attached, or 60.1%. It is spread thinly across 56 manufacturers, the largest accounting for just 11.7%. Among internal medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 708 payments — averaging $33.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alnylam Pharmaceuticals Inc.$3K
- Pfizer$2K
- Chiesi USA, Inc.$2K
- AstraZeneca$2K
- Jazz Pharmaceuticals Inc.$2K
- Novo Nordisk AS$2K
- plus $11K from 50 others
Across 4,817 payments — averaging $1674.27 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$1.3M
- AbbVie$1.1M
- Janssen Research & Development, LLC$988K
- Alnylam Pharmaceuticals Inc.$687K
- Seqirus USA Inc$659K
- Bavarian Nordic A/s$398K
- plus $2.9M from 30 others
What the payments were for
- Travel & lodging$9,41340%
- Food & beverage$14,19160%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BEVESPI AEROSPHERE$1,257
- SUVECALTAMIDE$123
How this compares
$23,604 in reported general payments places this provider in the 95th percentile of 8,530 internal medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cromolyn Sodium | 122 | $62,924 |
| CorlanorIvabradine Hcl | 43 | $41,435 |
| Nurtec OdtRimegepant Sulfate | 14 | $30,439 |
| OzempicSemaglutide | 13 | $21,303 |
| JardianceEmpagliflozin | 12 | $17,198 |
| RestasisCyclosporine | 16 | $15,249 |
| Midodrine Hcl | 76 | $14,656 |
| XareltoRivaroxaban | 21 | $11,437 |
| Emgality PenGalcanezumab-Gnlm | 11 | $10,486 |
| Droxidopa | 16 | $7,330 |
| Ivabradine Hcl | 16 | $7,129 |
| Lubiprostone | 13 | $5,225 |
| Clonidine | 33 | $4,168 |
| Cyclobenzaprine Hcl | 35 | $3,404 |
| Diphenhydramine Hcl | 55 | $3,063 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AmgenCorlanor | $636 | $41,43543 claims |
| PfizerNurtec Odt | $2,357 | $30,43914 claims |
| Novo NordiskOzempic | $612 | $21,30313 claims |
| Boehringer IngelheimJardiance | $300 | $17,19812 claims |
| AbbVieRestasis | $1,188 | $15,24916 claims |
| Johnson & JohnsonXarelto | $284 | $11,43721 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,530 internal medicine providers in Florida.
Other internal medicine in Clearwater
- Haytham ElgammalMiami$2.2M
- Keith RubinFort Lauderdale$2M
- Michael SensionFort Lauderdale$1M
- Quang NguyenOcala$434K
- Luis Correa LunaSanford$412K
- Michael OleksykFort Myers$365K
- Andrew KuykendallTampa$322K
- Howard FederoffCoconut Grove$302K
- Bianka EperjesiovaGainesville$260K
- Julio ConradoFort Myers$247K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.